Safety of Japanese encephalitis vaccines.

Safety of Japanese encephalitis vaccines.
复制标题

DOI:
10.1080/21645515.2021.1969852
复制
发表时间:
2021-11-02
影响因子:
4.8
通讯作者:
Lee PI
Lee PI
中科院分区:
医学3区
文献类型:
--
作者:
Hu YL;Lee PI

文献摘要

参考文献

被引文献

相似文献

日本脑炎(JE)是一种流行性疾病,主要发生在亚太地区,死亡率在3%至30%之间。30-50%的幸存者出现了长期的神经精神后遗症。目前尚无针对乙脑的抗病毒治疗方法。乙脑疫苗在预防这种毁灭性疾病方面发挥着重要作用。乙脑的发病率逐年下降,在乙脑免疫规划存在的国家,年龄分布向成年人转移。目前,小鼠脑乙脑疫苗被Vero细胞灭活疫苗和使用SA 14 -14-2株的减毒活疫苗以及乙脑嵌合活疫苗所取代。这三种类型的乙脑疫苗具有良好的疗效和安全性。常见的不良反应包括注射部位反应和发热,严重不良反应罕见。
Japanese encephalitis (JE) is an endemic disease dominantly in the Asia-Pacific region with mortality rate varying between 3% and 30%. Long-term neuropsychiatric sequelae developed in 30–50% of the survivors. There is no available antiviral therapy for JE. JE vaccines play a major role in preventing this devastating disease. The incidence of JE declined over years and the age distribution shifted toward adults in countries where JE immunization program exists. Mouse brain–JE vaccine is currently replaced by inactivated Vero cell-derived vaccine and live-attenuated vaccine using SA14-14-2 strain, and live chimeric JE vaccines. These three types of JE vaccines are associated with favorable efficacy and safety profiles. Common adverse reactions include injection site reactions and fever, and severe adverse reactions are rare.
DOI: 10.1056/nejm198809083191004
发表时间: 1988-09-08
影响因子: 158.5
作者:
HOKE, CH;NISALAK, A;BURKE, DS
通讯作者: BURKE, DS
DOI: 10.1016/j.vaccine.2004.03.027
发表时间: 2004-09-09
期刊: VACCINE
影响因子: 5.5
作者:
Beasley, DWC;Li, L;Barrett, ADT
通讯作者: Barrett, ADT
DOI: 10.4269/ajtmh.16-0330
发表时间: 2017-01-01
影响因子: 3.3
作者:
Chang, Yu-Kang;Chang, Hsiao-Ling;Chen, Kow-Tong
通讯作者: Chen, Kow-Tong
DOI: 10.1007/s40121-020-00305-6
发表时间: 2020-05-30
影响因子: 5.4
作者:
Kim, Hee Soo;Oh, Yongho;Yang, Kuhyun
通讯作者: Yang, Kuhyun
DOI: 10.1080/21645515.2017.1414763
发表时间: 2018-01-01
影响因子: 4.8
作者:
Chanthavanich, Pornthep;Limkittikul, Kriengsak;Zhumu, Bai
通讯作者: Zhumu, Bai